Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioNTech SE Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 8 | -$3.13 | -$1.37 | -$2.29 |
| Q2 2025 | 12 | -$4.61 | $5.05 | -$2.30 |
| Q3 2025 | 11 | -$7.38 | $2.35 | -$0.95 |
| Q4 2025 | 9 | -$0.63 | $0.14 | -$0.25 |
| Q1 2026 | 3 | -$3.81 | -$1.75 | -$2.29 |
| Q2 2026 | 1 | -$4.11 | -$1.89 | -$2.47 |
| Q3 2026 | 1 | -$0.80 | -$0.37 | -$0.48 |
| Q4 2026 | 1 | $1.08 | $2.36 | $1.42 |
BioNTech SE Earnings Date And Information
BioNTech SE last posted its earnings results on Monday, November 3rd, 2025. The company reported $-0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.75 by $0.89. The company had revenue of 1.52 B for the quarter and had revenue of 2.75 B for the year. BioNTech SE has generated $-3 earnings per share over the last year ($-2.77 diluted earnings per share) and currently has a price-to-earnings ratio of -57.55. BioNTech SE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 3rd, 2025 based on prior year's report dates.
BioNTech SE Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2025 | Q3 2025 | $0.75 | -$0.12 | -0.87 | $843.68 M | $1.52 B |
| 08/04/2025 | Q2 2025 | -$1.31 | -$1.60 | -0.29 | $177.80 M | $260.80 M |
| 03/31/2025 | Q1 2025 | N/A | -$1.73 | N/A | N/A | $182.80 M |
| 12/31/2024 | Q4 2024 | N/A | $1.08 | N/A | N/A | $1.19 B |
| 09/28/2024 | Q3 2024 | N/A | $0.83 | N/A | $572.38 M | $1.24 B |
| 06/28/2024 | Q2 2024 | N/A | -$3.42 | N/A | $145.36 M | $128.70 M |
| 03/30/2024 | Q1 2024 | N/A | -$1.31 | N/A | N/A | $187.60 M |
| 12/30/2023 | Q4 2023 | N/A | $1.88 | N/A | N/A | $1.48 B |
| 09/29/2023 | Q3 2023 | N/A | $0.69 | N/A | $899.06 M | $895.30 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.79 | N/A | $685.12 M | $167.70 M |
| 03/31/2023 | Q1 2023 | N/A | $2.05 | N/A | $1.15 B | $1.28 B |
| 12/31/2022 | Q4 2022 | N/A | $8.94 | N/A | $3.91 B | $4.28 B |
| 09/30/2022 | Q3 2022 | N/A | $6.98 | N/A | $2.02 B | $3.46 B |
| 06/30/2022 | Q2 2022 | N/A | $6.45 | N/A | $4.07 B | $3.20 B |
| 03/31/2022 | Q1 2022 | N/A | $14.24 | N/A | $4.80 B | $6.37 B |
| 12/31/2021 | Q4 2021 | N/A | $12.95 | N/A | $4.45 B | $5.53 B |
| 09/30/2021 | Q3 2021 | N/A | $13.14 | N/A | $5.90 B | $6.09 B |
| 06/30/2021 | Q2 2021 | N/A | $11.42 | N/A | $3.86 B | $5.31 B |
| 03/31/2021 | Q1 2021 | N/A | $4.64 | N/A | $1.71 B | $2.05 B |
| 12/31/2020 | Q4 2020 | N/A | $1.55 | N/A | $232.24 M | $345.44 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioNTech SE Earnings: FAQ's
BioNTech SE has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 3rd, 2025 based offlast year's report dates.
The conference call for BioNTech SE's latest earnings report can be listened to online.
The conference call transcript for BioNTech SE's latest earnings report can be read online.
BioNTech SE (:BNTX) has a recorded annual revenue of $2.75 B.
BioNTech SE (:BNTX) has a recorded net income of $-665,300,000.BioNTech SE has generated $-2.77 earnings per share over the last four quarters.
BioNTech SE (:BNTX) has a price-to-earnings ratio of -57.55 and price/earnings-to-growth ratio is -1.02.